BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3498778)

  • 1. [Subsets of chronic rheumatoid arthritis and changes in bone marrow].
    Ochi T
    Nihon Seikeigeka Gakkai Zasshi; 1987 May; 61(5):599-614. PubMed ID: 3498778
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum C1q level does not predict joint erosion in early rheumatoid arthritis.
    Möttönen T; Hannonen P; Rautiainen J; Jokinen I; Oka M; Arvilommi H
    Arthritis Rheum; 1989 Apr; 32(4):511-2. PubMed ID: 2784969
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis.
    Ochi T; Iwase R; Yonemasu K; Matsukawa M; Yoneda M; Yukioka M; Ono K
    Arthritis Rheum; 1988 Jan; 31(1):37-43. PubMed ID: 3257874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathological characteristics found in patients with severely involved rheumatoid arthritis].
    Ochi T
    Ryumachi; 1990 Aug; 30(4):287-300. PubMed ID: 2287970
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus.
    Rosano CL; Parhami N; Hechemy KE; Hurwitz C
    Inflammation; 1988 Aug; 12(4):351-60. PubMed ID: 3262584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement subcomponent C1q in rheumatic diseases].
    Yonemasu K; Sasaki T
    Ryumachi; 1986 Aug; 26(4):299-311. PubMed ID: 3551118
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 9. [The liquid phase C1q binding assay and its clinical application].
    Cheng PZ; Dong Y; Zhang NZ; Ji D; Dai X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):69-71. PubMed ID: 2954693
    [No Abstract]   [Full Text] [Related]  

  • 10. A method for serum C1q based on its hydroxyproline content.
    Rosano CL; Braun CB; Hurwitz C
    Clin Chem; 1987 Mar; 33(3):398-400. PubMed ID: 3102124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes.
    Hardin JA; Steere AC; Malawista SE
    Yale J Biol Med; 1984; 57(4):589-93. PubMed ID: 6334939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
    Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
    Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of immune complex levels--with special reference to C1q and the anti-antibody method].
    Kasukawa R
    Rinsho Byori; 1986 Oct; Spec No 69():35-44. PubMed ID: 3543438
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum C1q levels in rheumatoid arthritis.
    Parhami N; Rosano CL; Hurwitz C
    Arthritis Rheum; 1985 Feb; 28(2):240. PubMed ID: 3871619
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of circulating immune complexes in rheumatoid arthritis: comparison of 2 immunoenzyme methods].
    Bernardoni R; Soffritti E; Pelizzola D; Pazzi A; Accardo G
    Riv Emoter Immunoematol; 1985; 32(1):58-68. PubMed ID: 3909362
    [No Abstract]   [Full Text] [Related]  

  • 16. The presence of a myeloid cell population showing strong reactivity with monoclonal antibody directed to difucosyl type 2 chain in epiphyseal bone marrow adjacent to joints affected with rheumatoid arthritis (RA) and its absence in the corresponding normal and non-RA bone marrow.
    Ochi T; Hakomori S; Adachi M; Owaki H; Okamura M; Ono Y; Yamasaki K; Fujimoto M; Wakitani S; Ono K
    J Rheumatol; 1988 Nov; 15(11):1609-15. PubMed ID: 3236296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of C1 subunits in rheumatoid arthritis.
    Rosano CL; Parhami N; Hurwitz C
    J Lab Clin Med; 1984 Feb; 103(2):313-21. PubMed ID: 6319517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3 and C1q complement deposits in the membranous labyrinth of patients with Ménière's disease.
    Häusler R; Arnold W; Schifferli J
    Adv Otorhinolaryngol; 1988; 42():116-22. PubMed ID: 3063094
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis.
    Tomita T; Kashiwagi N; Shimaoka Y; Ikawa T; Tanabe M; Nakagawa S; Kawamura S; Denno K; Owaki H; Ochi T
    J Rheumatol; 1994 Sep; 21(9):1608-14. PubMed ID: 7799336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immuno-pathological studies on muscles of polymyositis and dermatomyositis].
    Yu MX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):279-82. PubMed ID: 2976316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.